Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021
Perspective

Comparison of Lyme Disease in the United States and Europe

Adriana R. MarquesComments to Author , Franc Strle, and Gary P. Wormser
Author affiliations: National Institutes of Health, Bethesda, Maryland, USA (A.R. Marques); University Medical Centre Ljubljana, Ljubljana, Slovenia (F. Strle); New York Medical College, Valhalla, New York, USA (G.P. Wormser)

Main Article

Figure 1

Erythema migrans skin lesions from patients in Europe (A, B) and the United States (C, D).

Figure 1. Erythema migrans skin lesions from patients in Europe (A, B) and the United States (C, D).

Main Article

Page created: June 21, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external